Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Escitalopram lowest risk of ADRs = lowest cost in depression

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Escitalopram lowest risk of ADRs = lowest cost in depression. Pharmacoecon. Outcomes News 464, 8 (2004). https://doi.org/10.2165/00151234-200404640-00020

    Download citation

    Keywords

    • Fluoxetine
    • Paroxetine
    • Sertraline
    • Venlafaxine
    • Escitalopram